Liquid Embolic Agent Market Size, Share, & Industry Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region

Description

List of Tables

The liquid embolic agents market size is expected to reach USD 613.05 million by 2034, according to a new study by Polaris Market Research. The report "Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type ((Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid embolic agents are minimally invasive solutions used for the treatment of cerebral arteriovenous malformations, aneurysms, and other vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH) copolymers, cyanoacrylate adhesives, and other specialized embolic materials.

Market growth is driven by the rising prevalence of neurovascular diseases, an expanding base of interventional neuroradiologists, and clinical advantages of liquid embolic agents over conventional treatments. Moreover, supportive reimbursement policies, regulatory clearances, and technological innovations in neurovascular intervention devices are reshaping the neurointerventional treatment landscape.

Liquid Embolic Agent Market Report Highlights

Based on product type, the ethylene vinyl alcohol (EVOH) segment dominated the market in 2024, driven by its favorable safety profile, controlled polymerization process, and widespread use in neurovascular embolization.

In terms of application, the arteriovenous malformations (AVMs) segment dominated the market in 2024, fueled by rising adoption of minimally invasive embolization procedures and supportive clinical evidence.

Based on end user, the hospitals accounted for the largest market share in 2024, supported by advanced neurointerventional facilities, availability of skilled specialists, and favorable insurance coverage.

North America dominated the liquid embolic agents market in 2024, fueled by strong regulatory approvals, advanced healthcare infrastructure and a large base of neurovascular disease patients.

Asia Pacific is projected to record the fastest CAGR during the forecast period, driven by increasing awareness, growing healthcare investments, and adoption of advanced embolization procedures across China, India, and Japan.

Key players in the global market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A., Arsenal Medical Inc., Meril Life Sciences Pvt. Ltd., and Chemence Medical Inc.

Polaris Market Research has segmented the market report based on product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Million, 2020-2034)

Ethylene Vinyl Alcohol Copolymer (EVOH)

Cyanoacrylates

N-BCA (n-Butyl Cyanoacrylate)

N-HCA (n-Hexyl Cyanoacrylate)

Other Products

By Application Outlook (Revenue, USD Million, 2020-2034)

Arteriovenous Malformations (AVM)

Hypervascular Tumors

Peripheral Vasculature Hemorrhage

Other Applications

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers (ASCs)

Other End Users

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM6327

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Liquid Embolic Agent Market Insights

4.1. Liquid Embolic Agent Market - Market Snapshot
4.2. Liquid Embolic Agent Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Global Rise in Neurological and Cancer-Related Vascular Conditions
  - 4.2.1.2. Government Healthcare Spending and Policies Promoting Advanced Therapies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Procedure Cost and Shortage of Skilled Interventional Radiologists
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Liquid Embolic Agent Market Trends
4.6. Value Chain Analysis

5. Global Liquid Embolic Agent Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
5.3. Ethylene Vinyl Alcohol Copolymer (EVOH)
- 5.3.1. Global Liquid Embolic Agent Market, by Ethylene Vinyl Alcohol Copolymer (EVOH), by Region, 2020-2034 (USD Million)
5.4. Cyanoacrylates
- 5.4.1. Global Liquid Embolic Agent Market, by Cyanoacrylates, by Region, 2020-2034 (USD Million)
5.5. Other Products
- 5.5.1. Global Liquid Embolic Agent Market, by Other Products, by Region, 2020-2034 (USD Million)

6. Global Liquid Embolic Agent Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
6.3. Arteriovenous Malformations (AVM)
- 6.3.1. Global Liquid Embolic Agent Market, by Arteriovenous Malformations (AVM), by Region, 2020-2034 (USD Million)
6.4. Hypervascular Tumors
- 6.4.1. Global Liquid Embolic Agent Market, by Hypervascular Tumors, by Region, 2020-2034 (USD Million)
6.5. Peripheral Vasculature Hemorrhage
- 6.5.1. Global Liquid Embolic Agent Market, by Peripheral Vasculature Hemorrhage, by Region, 2020-2034 (USD Million)
6.6. Other Applications
- 6.6.1. Global Liquid Embolic Agent Market, by Other Applications, by Region, 2020-2034 (USD Million)

7. Global Liquid Embolic Agent Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
7.3. Hospitals
- 7.3.1. Global Liquid Embolic Agent Market, by Hospitals, by Region, 2020-2034 (USD Million)
7.4. Specialty Clinics
- 7.4.1. Global Liquid Embolic Agent Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
7.5. Ambulatory Surgical Centers (ASCs)
- 7.5.1. Global Liquid Embolic Agent Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD Million)
7.6. Other End Users
- 7.6.1. Global Liquid Embolic Agent Market, by Other End Users, by Region, 2020-2034 (USD Million)

8. Global Liquid Embolic Agent Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Liquid Embolic Agent Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Liquid Embolic Agent Market - North America
- 8.3.1. North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.3.2. North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.3.4. Liquid Embolic Agent Market - U.S.
  - 8.3.4.1. U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.3.5. Liquid Embolic Agent Market - Canada
  - 8.3.5.1. Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
8.4. Liquid Embolic Agent Market - Europe
- 8.4.1. Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.4. Liquid Embolic Agent Market - UK
  - 8.4.4.1. UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.5. Liquid Embolic Agent Market - France
  - 8.4.5.1. France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.6. Liquid Embolic Agent Market - Germany
  - 8.4.6.1. Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.7. Liquid Embolic Agent Market - Italy
  - 8.4.7.1. Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.8. Liquid Embolic Agent Market - Spain
  - 8.4.8.1. Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.9. Liquid Embolic Agent Market - Netherlands
  - 8.4.9.1. Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.10. Liquid Embolic Agent Market - Russia
  - 8.4.10.1. Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.4.11. Liquid Embolic Agent Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
8.5. Liquid Embolic Agent Market - Asia Pacific
- 8.5.1. Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.4. Liquid Embolic Agent Market - China
  - 8.5.4.1. China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.5. Liquid Embolic Agent Market - India
  - 8.5.5.1. India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.6. Liquid Embolic Agent Market - Malaysia
  - 8.5.6.1. Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.7. Liquid Embolic Agent Market - Japan
  - 8.5.7.1. Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.8. Liquid Embolic Agent Market - Indonesia
  - 8.5.8.1. Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.9. Liquid Embolic Agent Market - South Korea
  - 8.5.9.1. South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.10. Liquid Embolic Agent Market - Australia
  - 8.5.10.1. Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.5.11. Liquid Embolic Agent Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
8.6. Liquid Embolic Agent Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.4. Liquid Embolic Agent Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.5. Liquid Embolic Agent Market - UAE
  - 8.6.5.1. UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.6. Liquid Embolic Agent Market - Israel
  - 8.6.6.1. Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.7. Liquid Embolic Agent Market - South Africa
  - 8.6.7.1. South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.6.8. Liquid Embolic Agent Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
8.7. Liquid Embolic Agent Market - Latin America
- 8.7.1. Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.4. Liquid Embolic Agent Market - Mexico
  - 8.7.4.1. Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.5. Liquid Embolic Agent Market - Brazil
  - 8.7.5.1. Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.6. Liquid Embolic Agent Market - Argentina
  - 8.7.6.1. Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
- 8.7.7. Liquid Embolic Agent Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Arsenal Medical Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Balt Group
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Chemence Medical Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Guerbet Group S.A.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Medtronic plc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Meril Life Sciences Pvt. Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Merit Medical Systems Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Penumbra Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Stryker Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Terumo Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development